Related Experiment Videos
[Current pharmacotherapy of heart insufficiency in old age]
Insights
Cardiovascular diseases affect over 50% of adults over 65. Effective management of congestive heart failure in the elderly requires age-specific considerations for treatment.
Area of Science:
- Geriatric Cardiology
- Cardiovascular Medicine
- Internal Medicine
Context:
- Cardiovascular diseases are prevalent in individuals over 65, impacting over 50% in industrialized nations.
- Congestive heart failure (CHF) is a significant cause of disability, affecting up to 49% of those aged 75-80.
- Current CHF treatment guidelines for the elderly yield suboptimal outcomes and frequent adverse effects.
Purpose:
- To highlight the necessity of age-specific management strategies for congestive heart failure in the elderly.
- To underscore the importance of considering age-related physiological changes in cardiovascular health.
- To emphasize the need for tailored pharmacological approaches in geriatric CHF patients.
Summary:
- Elderly patients exhibit unique age-related alterations in cardiac cells, myocardial structure, and vascular walls.
- Functional changes in cardiovascular regulation, including blunted reflexes and hormonal feedback loops, are common in older adults.
- Pharmacokinetic and pharmacodynamic differences in medications necessitate age-adapted treatment plans for elderly CHF patients.
Impact:
- Improved therapeutic efficacy for congestive heart failure in the elderly population.
- Reduced incidence of adverse drug reactions and treatment complications in geriatric patients.
- Advancement of personalized medicine approaches in geriatric cardiovascular care.
Abstract:
Signs of cardiovascular diseases have been found in more than 50% of elderly people over 65 years in industrialized countries. Congestive heart failure is an especially disabling consequence in up to 49% of the age-class 75 to 80 years. Treatment of these patients follows the same guidelines as in younger patients with congestive heart failure; however, treatment results are poor in many instances, and undesirable side effects are frequent. For an adequate management of congestive heart failure in the elderly, one should consider specific age-related changes of the heart muscle cell, of the myocardial structure, of the vessel wall as well as functional changes of cardiovascular regulation, e.g. blunted reflexes and disturbed feed-back loops of hormonal regulation. Moreover, pharmacokinetic and pharmacodynamic properties of medicaments differ in elderly people, which should be considered for an age-adapted specific management of congestive heart failure in this patient-group.